Thursday February 23, 2017 00:20

Food and Healthcare Press Releases

Improving data center performance at the University Hospital Basel with MNS-Up solution Heathcare—15 Feb 17

At the University Hospital Basel all patient information is stored digitally in the hospital's data center. It is essential that the facility's electrical infrastructure is the best that it can be – lives depend on it. The hospital decided to

Hearing Date of Thalidomide Lawsuit in Germany announced Heathcare—14 Feb 17

COLOGNE, Germany--14 Feb--PRNewswire/InfoQuest

60 years after the market launch of Contergan (active ingredient: thalidomide), the greatest pharmaceutical scandal in the Federal Republic of Germany continues to boil. A lawsuit will be heard in the Bonn Regional Court at 12:00 hrs on 15.2.2017 that is more explosive than appears at first sight.

The Contergan victim Andreas Meyer, who was born without arms or legs and is confined to a wheelchair, is suing the former member of the Management Board of the Contergan Foundation, Attorney Karl Schucht, for injunction and rectification.

In a letter to the members of the Family Affairs Committee of the German Federal Parliament, Schucht had asserted that Meyer, as an expert witness at a public hearing of the Committee, had publicly stated various untruths about events connected with the Contergan Foundation.

Meyer had said among other things that for 30 years the Contergan (thalidomide) manufacturer Grunenthal GmbH had had access to the medical files of the Contergan victims in the Contergan Foundation. In addition, Grunenthal had also paid the Foundation's medical experts.

In his letter, Schucht asserted to the contrary that Grunenthal had at no time had access to the medical files of the Contergan victims, but that the files were always kept by the Contergan Fo

Janssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Heathcare—14 Feb 17

- First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Heathcare—14 Feb 17

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for

Flexible Storage Options can Impact Daily Use of FVIII Treatments in People with Haemophilia Heathcare—01 Feb 17

Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the importance of flexible storage on daily use of FVIII treatments in people with haemophilia A.

Merck and Genea Open Centre of Excellence for Fertility Heathcare—20 Jan 17

- Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading

Ceva Completes Deal to Acquire Portfolio of Merial Swine and Cattle Vaccines and Nonsteroidal Heathcare—20 Jan 17

Ceva Sante Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal

Merck Opens Production Facility Exclusively for Meglumine in Spain Heathcare—18 Jan 17

Merck , a leading science and technology company, today announced the opening of a facility in Mollet des Valles, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast

Genea and Merck Open Fertility Centre of Excellence Heathcare—17 Jan 17

Australian fertility group Genea and German science and technology company Merck have today opened The Centre of Excellence for Fertility in Bangkok. The Centre of Excellence for Fertility has been developed with the goal of creating a global benchmark

OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Heathcare—11 Jan 17

Launch of Scoreflex(TM) NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has launched the Scoreflex NC, a

Merck Expands End-to-End Biodevelopment Centers in North America, China and Heathcare—11 Jan 17

- Biodevelopment centers in Boston, Mass. and Shanghai, China feature full suite of Merck technologies and services - New process development centers and full single-use GMP facility in France to accelerate development of biologics Merck , a leading

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Heathcare—05 Jan 17

Sun Pharma announced successful Phase 3 confirmatory clinical trial results for Seciera(TM) (cyclosporine A, 0.09% ophthalmic solution), for the treatment of dry eye disease. Seciera(TM) is a patented, novel, proprietary nanomicellar formulation of

Get yourself ready for the ultimate beauty trend of 2017 with Romrawin Heathcare—05 Jan 17

New Year is right around the corner! Ring in 2017 with confidence and discover the upcoming beauty trends from the insiders with Romrawin, premium beauty center and Thailand's leading aesthetic clinic, who will share with you what's hot and what's

Merck Acquires BioControl to Strengthen Position in Food Safety Testing Heathcare—05 Jan 17

- Enables Merck to offer its customers complete workflow solutions for food pathogen testing Merck , a leading life science and technology company, today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The

The First Dengue Vaccine in Thailand is Available at Samitivej Heathcare—28 Dec 16

On December 20th, 2016, Samitivej Hospital held a press conference on the evolution of dengue prevention in Thailand which has led to the introduction of the first vaccine against four strains of the dengue virus, reducing its severity and allowing a

BioNet Received Thai FDA Approval of the Worlds Only Available Recombinant Monovalent Acellular Heathcare—23 Dec 16

BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults BioNet-Asia announced today that its first recombinant acellular Pertussis booster vaccine containing a

Lancet Infectious Diseases Publishes Independent Double-Blind Study Validating MeMed#s Heathcare—22 Dec 16

Use of ImmunoXpert has the potential to improve patient management and reduce drug resistance due to antibiotic overuse ImmunoXpert significantly outperformed routine tests MeMed Ltd. announced today Lancet Infectious Diseases' publication of the

Photo Release: Bumrungrad receives 2016 AMCHAM CSR Excellence Award Heathcare—21 Dec 16

Mr. Ronald Lavater (5th from right), Bumrungrad's Corporate CEO, recently led the project's physicians and nursing team to receive the 4th award from H.E. Glyn Townsend Davies, the U.S. Ambassador to Thailand (5th from left). The award was granted by the

AGC Asahi Glass Signs Agreement to Acquire CMC Biologics Heathcare—20 Dec 16

BOTHELL, Washington and COPENHAGEN, Denmark and BERKELEY, California and TOKYO--20 Dec--PRNewswire/InfoQuest CMC Biologics to continue to provide CDMO services to the biopharma marketplace CMC Biologics, a global leader in clinical and commercial

AGC Signs Agreement for Acquisition of Leading Biopharmaceutical CDMO, CMC Heathcare—20 Dec 16

AGC Asahi Glass ("AGC"), a world-leading manufacturer of glass, chemicals and high-tech materials, announced on December 20 that it has entered into an agreement to acquire 100% of the shares in CMC Biologics ("CMC"), a world-leading biologics active

OGT Expands Cytocell Sarcoma FISH Probe Range Heathcare—16 Dec 16

Oxford Gene Technology[ http://www.ogt.com ] (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius(R) fluorescence in situ hybridisation (FISH) probes for pathology. OGT has introduced three new probes: FUS Breakapart and

USC Leonard Davis School ประกาศแต่งตั้งผู้ดำรงตำแหน่ง Kevin Xu Chair in Heathcare—15 Dec 16

เมื่อวันจันทร์ที่ 12 ธันวาคมที่ผ่านมา ณ ห้องบอลรูม USC Town and Gown คุณพินชาส โคเฮน คณบดีประจำ USC Leonard Davis School of Gerontology ได้ประกาศสถาปนาตำแหน่ง Kevin Xu Chair in Gerontology รวมถึงประกาศคุณงามความดีของ Rongxiang Xu Regenerative Life

Kevin Xu Chair in Gerontology is installed at USC Leonard Davis School Heathcare—15 Dec 16

At USC Town and Gown on Monday, December 12, USC Leonard Davis School of Gerontology Dean Pinchas Cohen announced the installation of Kevin Xu Chair in Gerontology and the dedication of Rongxiang Xu Regenerative Life Science Lab, made possible with

International Group Supports Global Efforts To End Dental Mercury Usage Heathcare—15 Dec 16

Last week, three EU institutions (the European Parliament, the European Commission and the Council of the European Union) reached a provisional agreement to ban dental amalgam fillings for children under 15 and pregnant and breastfeeding women as of July